2019 Research Grants AnnouncedThe Neuroendocrine Tumor Research Foundation (NETRF) has announced a new round of research grant opportunities. Its 2019 Request for Applications (RFA) invites innovative research applications in neuroendocrine tumors (NETs) that can bring the field closer to more effective therapies. The grants range from $100,000 to $1.2 million to support projects ranging from one year to four years for basic, translational, or clinical research. The deadline is 6/17/19. (MORE)
| |
Introducing NETRF Mentored Research Award Essential Funding for Early Career InvestigatorsNETRF is pleased to announce a new two-year Mentored Award for researchers currently in post-doctoral, fellowship, or residency positions. Made possible by a grant from IPSEN, this award is designed to support early career investigators to launch a career in neuroendocrine cancer research. (MORE)
| |
NANETS/NETRF Grant Award OpportunityNETRF partners with the North American Neuroendocrine Tumor Society (NANETS) to offer the Basic Translational Science Investigator (BTSI) award.The BTSI is awarded to scientists at the end of their fellowship or in the beginning of their faculty appointment, who are predominantly focused on lab-based, basic/translational NET research. The deadline is 6/14/19. (MORE)
| |
Partnering with Broad Institute to Develop NET Cell LineThe lack of publicly available, reliable NET cell lines is a barrier in neuroendocrine tumor research, and a new collaborative program between the Neuroendocrine Tumor Research Foundation and Broad Institute of MIT and Harvard University aims to change that.
Cell lines are used as a laboratory model to understand the genomics of tumors, test drugs for effectiveness, and identify vulnerabilities to kill cancer cells. They are fundamental research tools used in every type of cancer research. The lack of reliable NET cell lines holds back meaningful research in this rare tumor type. The NETRF/Broad Institute Cell Line Project aims to create publicly available tumor cell lines to be shared with any researcher, in any laboratory, anywhere in the world. (MORE)
| |
Research Symposium Highlights ProgressAt NETRF's 11th Annual Research Symposium more than 100 neuroendocrine tumor researchers and clinicians from eight countries came together to share progress and plans to advance the knowledge and treatment of NETs. Early NETRF-funded researcher Matthew Meyerson, MD, Dana-Farber Cancer Institute (above), recognized what visible progress has been made over the years that the meeting has been held. “Remarkable progress has been made in the last ten-plus years. It is truly extraordinary. It has gone from a question of whether it can be done to seeing it and being amazed at how well it can be done.” (MORE)
| |
Rocks of HopeOffered at Fundraiser
Susan Garrett coped with anger and depression following her NET diagnosis by carrying on with "Rocks of Hope," a tradition started by Ashley Linden, a NET patient from her area who passed in January. Garrett's friends and family paint colorful designs and inspirational messages on rocks and leave them in places so they might bring others hope and inspiration. Painting rocks has helped Garrett move from a place of darkness to a place of joy and hope, so much so that she and her family decided to give back with a NETRF fundraiser, Slam Dunkin' the NETs. The event is planned for Saturday, May 18, 10 am - 2 pm, at the Concord United Methodist Church in Roxboro, NC. In addition to rock painting, there will be face painting, basketball, music, and a hotdog lunch to raise money in support of NETRF. (MORE)
| |
Former Board Member Honored for His Service
NETRF Board members, grantees, supporters, and staff joined together at the Harvard Club of Boston earlier this month to celebrate NETRF's generous supporters, receive a research update, and honor Nick Vantzelfde, a long-time board member. Fellow board member Steve Kaufer was the host and welcomed all guests to the dinner. Board Chair, Joe Li, MD presented Nick Vantzelfde with a service award and announced his appointment as the Foundation's first Director Emeritus. "We are grateful for NIck's many accomplishments and service over the years," said Li. "Nick was instrumental in helping the Foundation develop its overall financial infrastructure including fiscal protocols and systems. We have Nick to thank for the Foundation's years of transparency and financial stewardship recognition by external charity rating services." Nick Vantzelfde joined the board of directors in 2008. He and his wife, Lauren Erb, have been loyal supporters of NETRF's mission and research investments for many years. Thank you, Nick!
| |
Are You Having Surgery?Help advance neuroendocrine tumor research by donating tumor tissue. By contributing tumor tissue from a surgery, biopsy, or fluid drain, you make it possible for researchers to study your cancer type. This helps researchers study NETs and test treatment ideas. Through a unique collaboration with Pattern.org, we are working to make it easier than ever for you to help fuel research with tumor tissue donation. (MORE)
| |
Discovering the Role of Exercise in Survivorship
Exercise can help improve emotional well-being, sleep, body image, and reduce cancer-related fatigue. So why is it so hard to do? Sixty percent of cancer patients say their illness forces them to reduce activity. Learn what, when, and how you can find an exercise program for you. (MORE)
| |
2019 LACNETS ConferenceSaturday, June 8, Los Angeles The 2019 LACNETS conference will include several presentations on PRRT as well as Gallium-68 dotatate scans, carcinoid syndrome, surgery, liver-directed therapy, pathology, and clinical trials. Learn from the physician panel as they discuss NET case studies to show how they make treatment sequencing decisions.
This conference also allows patients and caregivers to connect with other NET patients and caregivers. NETRF is proud to continue its support of the annual LACNETS conference. (MORE)
| |
|
|
| Fnewly
|
|
